Dr Martin Reeves is set to switch from the same role at Coventry City Council, a post he has held since 2009, after the move was confirmed at a meeting of the full council on Tuesday, 13 December.
The park and ride – located on the A40 eastbound in Eynsham – is part of a significant investment in the A40 to deliver better facilities for those walking, cycling and using public transport.
The new homes will be a combination of one-, two- and three-bed flats set in adjacent three-storey apartment blocks, providing 14 social rent homes and a further 11 homes under a shared ownership scheme.
The development in Littlemore Park, just three miles south of Oxford city centre, will bring a total of 273 new affordable homes to the area, with 162 for shared ownership and 111 for social rent, with priority purchase options given to NHS key workers.
She has taken a new full-time job with a local charity and put forward her deputy Councillor Bethia Thomas (Lib Dem, Faringdon) as her replacement.
The county’s cabinet member for finance, was fielding questions from the performance and corporate services overview and scrutiny committee over initial proposals for the council’s budget from April 2023.
The council has balanced the budget despite facing unprecedented financial pressures as a result of rising inflation and interest rates, the economic downturn and the legacy impacts of the COVID-19 pandemic on some key income streams.
The funding will enable the startup company to expand its scale up its home care network and operations across the rest of Oxfordshire and into neighbouring Buckinghamshire.
District councillors at the Vale unanimously agreed to remove the restrictions requiring low-income households to contribute towards their annual council tax bill.
The consultation is a chance to see how the project has evolved since the design development consultation this summer and the initial consultation held in Autumn 2021.
The early-stage drug discovery company with operations in Oxford and Boston is looking to increase its drug discovery and validation capabilities in key neuro disease areas.